Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lei Huo

Showing results (201-210 of 222) with videos related to

Pageof 23
Sort By:
Breast Cancer Research and Treatment|April 15, 2023
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancerClinton Yam, Elizabeth A Mittendorf, Haven R Garber, et al.
Cancer Research|August 13, 2025
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples During Neoadjuvant ChemotherapyAmanda L Rinkenbaugh, Yuan Qi, Shirong Cai, et al.
Cancers|March 10, 2022
Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast CancerNour Abuhadra, Ryan Sun, Jennifer K Litton, et al.
JCO Precision Oncology|December 18, 2025
Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerBeatriz E Adrada, Mary S Guirguis, Lei Huo, et al.
Radiology. Imaging Cancer|July 28, 2023
A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast CancerKen-Pin Hwang, Nabil A Elshafeey, Aikaterini Kotrotsou, et al.
Human Pathology|January 22, 2022
Expression of TRPS1 in phyllodes tumor and sarcoma of the breastJing Wang, Wei-Lien Wang, Hongxia Sun, et al.
NPJ Breast Cancer|January 10, 2023
Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancerGloria V Echeverria, Shirong Cai, Yizheng Tu, et al.
Scientific Reports|July 11, 2024
Multiparametric MRI-based radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancerRania M Mohamed, Bikash Panthi, Beatriz E Adrada, et al.
Cell Reports. Medicine|June 5, 2024
Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into "ARness"Bora Lim, Sahil Seth, Clinton Yam, et al.
Frontiers in Oncology|November 9, 2023
Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancerBikash Panthi, Rania M Mohamed, Beatriz E Adrada, et al.
Pageof 23

Showing results (201-210 of 222) with videos related to

Sort By:
Pageof 23
Breast Cancer Research and Treatment|April 15, 2023
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancerClinton Yam, Elizabeth A Mittendorf, Haven R Garber, et al.
Cancer Research|August 13, 2025
An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naïve and Longitudinal Samples During Neoadjuvant ChemotherapyAmanda L Rinkenbaugh, Yuan Qi, Shirong Cai, et al.
Cancers|March 10, 2022
Prognostic Impact of High Baseline Stromal Tumor-Infiltrating Lymphocytes in the Absence of Pathologic Complete Response in Early-Stage Triple-Negative Breast CancerNour Abuhadra, Ryan Sun, Jennifer K Litton, et al.
JCO Precision Oncology|December 18, 2025
Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerBeatriz E Adrada, Mary S Guirguis, Lei Huo, et al.
Radiology. Imaging Cancer|July 28, 2023
A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast CancerKen-Pin Hwang, Nabil A Elshafeey, Aikaterini Kotrotsou, et al.
Human Pathology|January 22, 2022
Expression of TRPS1 in phyllodes tumor and sarcoma of the breastJing Wang, Wei-Lien Wang, Hongxia Sun, et al.
NPJ Breast Cancer|January 10, 2023
Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancerGloria V Echeverria, Shirong Cai, Yizheng Tu, et al.
Scientific Reports|July 11, 2024
Multiparametric MRI-based radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancerRania M Mohamed, Bikash Panthi, Beatriz E Adrada, et al.
Cell Reports. Medicine|June 5, 2024
Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into "ARness"Bora Lim, Sahil Seth, Clinton Yam, et al.
Frontiers in Oncology|November 9, 2023
Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancerBikash Panthi, Rania M Mohamed, Beatriz E Adrada, et al.
Pageof 23